27677346|t|Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3 - dependent and STAT3 - independent pathways
27677346|a|The study aimed to investigate the effects of combination treatment of curcumin and β-interferon (IFN-β)/ retinoic acid (RA) on breast cancer cells, including cell viability, apoptosis and migration, and to determine the mechanisms related to GRIM-19 through STAT3 - dependent and STAT3 - independent pathways. The following groups were used for the in vitro experiment: control siRNA, GRIM-19 siRNA, IFN-β / RA and IFN-β / RA + curcumin. Cell viability is by the MTT method, cell apoptosis by flow cytometry and cell migration by wound healing experiment; GRIM-19, STAT3, survivin, Bcl-2, GADD153 and COX-2 expression was measured by Western blot. In vivo experiment, MCF-7 cells were subcutaneously injected into nude mice. GRIM-19 siRNA promoted MCF-7 cell proliferation and migration; inhibited cell apoptosis; and promoted the expression of STAT3, survivin, Bcl-2 and MMP-9. IFN-β / RA inhibited cell proliferation and migration; promoted cell apoptosis; up-regulated GRIM-19; and inhibited the expression of STAT3, survivin, Bcl-2 and MMP-9. Combination treatment of curcumin and IFN-β / RA had a stronger effect than that of the IFN-β / RA group. In addition, curcumin and IFN-β / RA combination inhibited the expression of COX-2 and up-regulated GADD153. Curcumin synergistically increases the effects of IFN-β / RA on breast cancer cells. The mechanism may be related to the up-regulation of GRIM-19 through STAT3 - dependent and STAT3 - independent pathways.
27677346	0	8	Curcumin	T103	UMLS:C0010467
27677346	46	58	β-interferon	T103	UMLS:C0015980
27677346	63	76	retinoic acid	T103	UMLS:C0035339
27677346	80	99	breast cancer cells	T017	UMLS:C1512505
27677346	113	120	in vivo	T082	UMLS:C1515655
27677346	124	137	up-regulation	T038	UMLS:C0041904
27677346	141	148	GRIM-19	T103	UMLS:C1448171
27677346	157	162	STAT3	T103	UMLS:C0253050
27677346	179	184	STAT3	T103	UMLS:C0253050
27677346	199	207	pathways	T038	UMLS:C0037080
27677346	212	217	study	T062	UMLS:C2603343
27677346	254	275	combination treatment	T058	UMLS:C0013218
27677346	279	287	curcumin	T103	UMLS:C0010467
27677346	292	304	β-interferon	T103	UMLS:C0015980
27677346	306	311	IFN-β	T103	UMLS:C0015980
27677346	314	327	retinoic acid	T103	UMLS:C0035339
27677346	329	331	RA	T103	UMLS:C0035339
27677346	336	355	breast cancer cells	T017	UMLS:C1512505
27677346	367	381	cell viability	T038	UMLS:C0007620
27677346	383	392	apoptosis	T038	UMLS:C0162638
27677346	397	406	migration	T038	UMLS:C0027627
27677346	415	424	determine	T058	UMLS:C1148554
27677346	451	458	GRIM-19	T103	UMLS:C1448171
27677346	467	472	STAT3	T103	UMLS:C0253050
27677346	489	494	STAT3	T103	UMLS:C0253050
27677346	509	517	pathways	T038	UMLS:C0037080
27677346	567	577	experiment	T062	UMLS:C0681814
27677346	587	592	siRNA	T103	UMLS:C1099354
27677346	594	601	GRIM-19	T017	UMLS:C1826393
27677346	602	607	siRNA	T103	UMLS:C1099354
27677346	609	614	IFN-β	T103	UMLS:C0015980
27677346	617	619	RA	T103	UMLS:C0035339
27677346	624	629	IFN-β	T103	UMLS:C0015980
27677346	632	634	RA	T103	UMLS:C0035339
27677346	637	645	curcumin	T103	UMLS:C0010467
27677346	647	661	Cell viability	T038	UMLS:C0007620
27677346	672	682	MTT method	T062	UMLS:C2986858
27677346	684	698	cell apoptosis	T038	UMLS:C0162638
27677346	702	716	flow cytometry	T058	UMLS:C0016263
27677346	721	735	cell migration	T038	UMLS:C1622501
27677346	739	752	wound healing	T038	UMLS:C0043240
27677346	753	763	experiment	T062	UMLS:C0681814
27677346	765	772	GRIM-19	T103	UMLS:C1448171
27677346	774	779	STAT3	T103	UMLS:C0253050
27677346	781	789	survivin	T103	UMLS:C0664336
27677346	791	796	Bcl-2	T103	UMLS:C0107696
27677346	798	805	GADD153	T103	UMLS:C0170521
27677346	810	815	COX-2	T103	UMLS:C1565860
27677346	816	826	expression	T038	UMLS:C1171362
27677346	843	855	Western blot	T058	UMLS:C0949466
27677346	857	864	In vivo	T082	UMLS:C1515655
27677346	865	875	experiment	T062	UMLS:C0681814
27677346	877	888	MCF-7 cells	T017	UMLS:C0596890
27677346	894	917	subcutaneously injected	T033	UMLS:C1736929
27677346	923	932	nude mice	T204	UMLS:C0025932
27677346	934	941	GRIM-19	T017	UMLS:C1826393
27677346	942	947	siRNA	T103	UMLS:C1099354
27677346	957	967	MCF-7 cell	T017	UMLS:C0596890
27677346	968	981	proliferation	T038	UMLS:C0596290
27677346	986	995	migration	T038	UMLS:C0027627
27677346	1007	1021	cell apoptosis	T038	UMLS:C0162638
27677346	1040	1050	expression	T038	UMLS:C1171362
27677346	1054	1059	STAT3	T103	UMLS:C0253050
27677346	1061	1069	survivin	T103	UMLS:C0664336
27677346	1071	1076	Bcl-2	T103	UMLS:C0107696
27677346	1081	1086	MMP-9	T103	UMLS:C0165519
27677346	1088	1093	IFN-β	T103	UMLS:C0015980
27677346	1096	1098	RA	T103	UMLS:C0035339
27677346	1109	1127	cell proliferation	T038	UMLS:C0596290
27677346	1132	1141	migration	T038	UMLS:C0027627
27677346	1152	1166	cell apoptosis	T038	UMLS:C0162638
27677346	1168	1180	up-regulated	T038	UMLS:C0041904
27677346	1181	1188	GRIM-19	T103	UMLS:C1448171
27677346	1208	1218	expression	T038	UMLS:C1171362
27677346	1222	1227	STAT3	T103	UMLS:C0253050
27677346	1229	1237	survivin	T103	UMLS:C0664336
27677346	1239	1244	Bcl-2	T103	UMLS:C0107696
27677346	1249	1254	MMP-9	T103	UMLS:C0165519
27677346	1256	1277	Combination treatment	T058	UMLS:C0013218
27677346	1281	1289	curcumin	T103	UMLS:C0010467
27677346	1294	1299	IFN-β	T103	UMLS:C0015980
27677346	1302	1304	RA	T103	UMLS:C0035339
27677346	1344	1349	IFN-β	T103	UMLS:C0015980
27677346	1352	1354	RA	T103	UMLS:C0035339
27677346	1375	1383	curcumin	T103	UMLS:C0010467
27677346	1388	1393	IFN-β	T103	UMLS:C0015980
27677346	1396	1398	RA	T103	UMLS:C0035339
27677346	1425	1435	expression	T038	UMLS:C1171362
27677346	1439	1444	COX-2	T103	UMLS:C1565860
27677346	1449	1461	up-regulated	T038	UMLS:C0041904
27677346	1462	1469	GADD153	T103	UMLS:C0170521
27677346	1471	1479	Curcumin	T103	UMLS:C0010467
27677346	1521	1526	IFN-β	T103	UMLS:C0015980
27677346	1529	1531	RA	T103	UMLS:C0035339
27677346	1535	1554	breast cancer cells	T017	UMLS:C1512505
27677346	1592	1605	up-regulation	T038	UMLS:C0041904
27677346	1609	1616	GRIM-19	T103	UMLS:C1448171
27677346	1625	1630	STAT3	T103	UMLS:C0253050
27677346	1647	1652	STAT3	T103	UMLS:C0253050
27677346	1667	1675	pathways	T038	UMLS:C0037080